Idiopathic Hypersomnia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Pharmacokinetic and Safety Study of TAK-925 in Participants With Idiopathic Hypersomnia
Condition: Idiopathic Hypersomnia Interventions: Drug: TAK-925; Drug: TAK-925 Placebo Sponsor: Millennium Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2019 Category: Research Source Type: clinical trials
Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
Conditions: Idiopathic Hypersomnia; Narcolepsy Without Cataplexy Interventions: Drug: Modafinil; Drug: Amphetamine-Dextroamphetamine Sponsors: Emory University; American Academy of Sleep Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2018 Category: Research Source Type: clinical trials